Cargando…

Vaccination coverage estimates and utilization patterns of inactivated enterovirus 71 vaccine post vaccine introduction in Ningbo, China

BACKGROUND: In China, enterovirus 71 (EV71) is the major etiological agents of hand foot mouth disease that poses severe risks to children’s health. Since 2015, three inactivated EV71 vaccines have been approved for use. Previous studies indicated the high willingness of EV71 vaccination in eastern...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Lixia, Chen, Jieping, Fang, Ting, Ma, Rui, Wang, Jianmei, Pan, Xingqiang, Dong, Hongjun, Xu, Guozhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194148/ https://www.ncbi.nlm.nih.gov/pubmed/34112128 http://dx.doi.org/10.1186/s12889-021-11198-6

Ejemplares similares

Inactivated enterovirus A71 vaccines and moving forward
por: Shimizu, Hiroyuki
Publicado: (2021)

Enterovirus 71 infection and vaccines
por: Yi, Eun-Je, et al.
Publicado: (2017)

Enterovirus A71 Vaccines
por: Li, Mei-Ling, et al.
Publicado: (2021)

Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine
por: Hwa, Shi-Hsia, et al.
Publicado: (2013)

Challenges to Licensure of Enterovirus 71 Vaccines
por: Lee, Min-Shi, et al.
Publicado: (2012)

112 The Development of Enterovirus 71 Vaccine
por: Xiuling, Li, et al.
Publicado: (2014)

Antivirals and vaccines for Enterovirus A71
por: Lin, Jing-Yi, et al.
Publicado: (2019)

The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China
por: Jiang, Hongchao, et al.
Publicado: (2021)

Development of Novel Vaccines against Enterovirus-71
por: Yee, Pinn Tsin Isabel, et al.
Publicado: (2015)

Enterovirus 71 vaccine: close but still far
por: Zhang, Dingmei, et al.
Publicado: (2010)

Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in Macaques
por: Liu, Chia-Chyi, et al.
Publicado: (2014)

Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice
por: Chang, Junliang, et al.
Publicado: (2015)

A Bivalent Inactivated Vaccine Prevents Enterovirus 71 and Coxsackievirus A16 Infections in the Mongolian Gerbil
por: Yi, Eun-Je, et al.
Publicado: (2023)

Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations
por: Liu, Longding, et al.
Publicado: (2015)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
por: Chen, Yaping, et al.
Publicado: (2022)

Risk of peripheral facial palsy following parenteral inactivated influenza vaccination in the elderly Chinese population
por: Yang, Tianchi, et al.
Publicado: (2023)

Effects of Varicella Vaccine Time of First Dose and Coverage of Second Dose — Beijing and Ningbo, China, 2012–2018
por: Chen, Yuewei, et al.
Publicado: (2020)

Transplantation of Enterovirus 71 Virion Protein Particle Vaccine Protects Against Enterovirus 71 Infection in a Neonatal Mouse Model
por: Lei, Li, et al.
Publicado: (2021)

T Cell Immunity To Enterovirus 71 Infection In Humans And Implications For Vaccine Development
por: Yee, Pinn Tsin Isabel, et al.
Publicado: (2018)

Efficient expression of enterovirus 71 based on virus-like particles vaccine
por: Kim, Hye-Jin, et al.
Publicado: (2019)

Cost-effectiveness of a national enterovirus 71 vaccination program in China
por: Wang, Wenjun, et al.
Publicado: (2017)

Epidemiological surveillance of hand, foot and mouth disease in Shanghai in 2014–2016, prior to the introduction of the enterovirus 71 vaccine
por: Li, Jingjing, et al.
Publicado: (2018)

Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates
por: Chou, Ai-Hsiang, et al.
Publicado: (2012)

DNA vaccine constructs against enterovirus 71 elicit immune response in mice
por: Tung, Wong Siew, et al.
Publicado: (2007)

Monitoring Antigenic Variations of Enterovirus 71: Implications for Virus Surveillance and Vaccine Development
por: Chia, Min-Yuan, et al.
Publicado: (2014)

Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis
por: Wu, Joseph T., et al.
Publicado: (2016)

Characterization of human enterovirus71 virus-like particles used for vaccine antigens
por: Zhao, Dandan, et al.
Publicado: (2017)

Enterovirus 71-Associated Infection in South Vietnam: Vaccination Is a Real Solution
por: Romanenkova, Natalia I., et al.
Publicado: (2023)

Correction: Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis
por: Wu, Joseph T., et al.
Publicado: (2016)

Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China
por: Wang, Xiaoli, et al.
Publicado: (2019)

Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections
por: Liu, Jiangning, et al.
Publicado: (2020)

Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development
por: Chang, Yu-Kang, et al.
Publicado: (2018)

Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in China
por: Liu, Xiaodong, et al.
Publicado: (2022)

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
por: Mao, Qunying, et al.
Publicado: (2016)

Protective effect of enterovirus-71 (EV71) virus-like particle vaccine against lethal EV71 infection in a neonatal mouse model
por: CAO, LEI, et al.
Publicado: (2015)

Co-infection and enterovirus B: post EV-A71 mass vaccination scenario in China
por: Guo, Wei, et al.
Publicado: (2022)

Study of the Integrated Immune Response Induced by an Inactivated EV71 Vaccine
por: Liu, Longding, et al.
Publicado: (2013)

Progress on the research and development of inactivated EV71 whole-virus vaccines
por: Liang, Zheng-Lun, et al.
Publicado: (2013)

Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial
por: Tong, Yeqing, et al.
Publicado: (2022)

A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro
por: Yang, Ting, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_87v3vqlatdm99b7me6ds7bhp5p